What's the outlook for ASX healthcare shares in Q2?

Here are some of the numbers looking ahead.

| More on:
A doctor appears shocked as he looks through binoculars on a blue background.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX healthcare shares have been underwhelming this year
  • Projections for the industry are a little more optimistic, with some of the larger players looking to secure gains
  • We've crunched the numbers to see what's on the horizon for the industry

ASX healthcare shares have been a mixed bag in 2022. The industry was flourishing during the later part of the last calendar year but took a turn as early as November.

The downside continued along with the broader sell-off in equities. However, unlike most other industries, it has failed to reclaim a good portion of the losses.

The S&P/ASX 200 Health Care Index (ASX: XHJ) is down more than 10% this year to date and is sitting around the same over the past 12 months.

What are the projections?

Healthcare is seen as a 'defensive' industry that is largely insensitive to the business cycle. With this in mind, the current and forward-looking economic climate are of interest to those looking at ASX healthcare shares.

The industry trades on a price-to-earnings (P/E) ratio of 30.09 times at the time of writing, and has delivered a trailing dividend yield of 1.62%.

Some of the largest players, such as CSL Limited (ASX: CSL), Resmed Inc (ASX: RMD), and Sonic Healthcare Limited (ASX: SHL), reside within this portion of the market.

Each of these dominant names has numerous bullish price targets that point to strength in the industry across a diverse array of services.

CSL is rated a buy from 13 out of 16 brokers covering the share, with a $320 consensus price target (all data sourced from Refinitiv Eikon). The CSL share price closed on Friday at $280.43.

Meanwhile, Resmed is also tipped as a buy from nine out of 14 analysts, with a consensus valuation of $36.10. Resmed shares ended Friday's session trading for $34.14 apiece.

Sonic is rated a buy from six out of the 15 analysts covering it, with a $35.86 price target assigned. The Sonic share price is $30.55 as of Friday's close.

Noteworthy is that each consensus price target is priced above the current market value of each share.

In addition, some of the largest ASX healthcare shares are posted in the table below, with their respective fundamentals. All figures are in millions of dollars (except earnings per share and percentage).

NameRevenue [$million]EBITDANet IncomeEPSFree Cash FlowROE (%)
S&P/ASX 200 Health Care Index (ASX: XHJ)1,992.3514.4281.6 $     0.8898.816.3
CSL Limited (ASX: CSL)15,304.95534.73267.2 $     6.97740.219.6
Resmed Inc (ASX: RMD)5,185.01683.51129.5 $     7.68779.125.0
Sonic Healthcare Limited (ASX: SHL)9,340.22835.81460.6 $     3.021356.921.4
Ramsay Health Care Limited (ASX: RHC)13,210.21334.1274.0 $     1.16229.36.9
Cochlear Limited (ASX: COH)1,648.3471.2289.1 $     4.4095.117.1
Fisher & Paykel Healthcare Corporation Ltd (ASX: FPH)15,58.9557.7349.4 $     0.6072.523.6
Pro Medicus Limited (ASX: PME)94.169.344.4 $     0.4223.948.5
Ansell Limited (ASX: ANN)2,828.7470.9230.0 $     1.79102.610.3
Healius Ltd (ASX: HLS)2,336.2766.9307.9 $     0.52380.915.6
Telix Pharmaceuticals Ltd (ASX: TLS)7.6-71.8-80.5 $   (0.29)-76.7-198.4
Imugene Limited (ASX: IMU)0.0-35.3-37.9 $   (0.01)-35.7-37.2
Nanosonics Ltd (ASX: NAN)120.37.63.7 $     0.012.52.7

With that, we can observe some names from the above list with projected earnings over the next two years in the table below as well.

 EPS   
NamePrevThis yearFY24FY25
S&P/ASX 200 Health Care (GIC) $   1.32 $   0.86 $   1.18 $   1.56
Resmed Inc $   4.32 $   7.68 $   8.47 $   9.46
CSL Ltd $   6.94 $   6.97 $   8.56 $ 10.40
Cochlear Ltd $   4.97 $   4.40 $   5.31 $   6.65
Sonic Healthcare Ltd $   2.73 $   3.02 $   1.72 $   1.56
Ansell Ltd $   2.53 $   1.79 $   2.23 $   2.09
Ramsay Health Care Ltd $   1.80 $   1.13 $   2.98 $   3.13
Fisher & Paykel Healthcare Corporation Ltd $   0.83 $   0.60 $   0.64 $   0.74
Healius Ltd $   0.11 $   0.50 $   0.21 $   0.22
Pro Medicus Ltd $   0.29 $   0.42 $   0.54 $   0.65
Nanosonics Ltd $   0.03 $   0.01 $   0.09 — 
Imugene Ltd $ (0.00) $ (0.01) $ (0.01) $ (0.01)
Telix Pharmaceuticals Ltd $ (0.17) $ (0.29) $ (0.30) $ (0.03)

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL Ltd. and ResMed Inc. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended ResMed. The Motley Fool Australia has positions in and has recommended ResMed Inc. The Motley Fool Australia has recommended Sonic Healthcare Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A red heart-shaped balloon floats up above the plain white ones, indicating the best shares.
Healthcare Shares

Heart tech firm's shares surge after huge capital raise

A strategic investor has also jumped on board.

Read more »

Lab technician in lab with a tray of specimens
Healthcare Shares

Has this ASX 200 stock just turned the corner after 7% surge?

Brokers think the volatile biotech share can sustain the rally this time.

Read more »

Green stock market graph with a rising arrow symbolising a rising share price.
Opinions

3 ASX shares tipped to climb over 100% in 2026

Analysts expect steep gains this year.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Opinions

4DMedical shares crash 20% this week: Should investors cut their losses on the once-booming stock?

The shares are now down 6.61% for the year to date.

Read more »

A woman researcher holds a finger up in happiness as if making the 'number one' sign with a graphic of technological data and an orb emanating from her finger while fellow researchers work in the background.
Healthcare Shares

Top broker tips 57% upside for beaten-down Telix shares

A leading broker expects a big rebound in Telix shares in 2026.

Read more »

Research, collaboration and doctors working digital tablet, analysis and discussion of innovation cancer treatment. Healthcare, teamwork and planning by experts sharing idea and strategy for surgery.
Healthcare Shares

Here's why Anteris shares are in a trading halt today

The company is undertaking a US$300m capital raising.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Telix shares in focus as the company meets guidance

More good news from the drug developer.

Read more »

Doctor sees virtual images of the patient's x-rays on a blue background.
Healthcare Shares

What are the healthcare stocks where RBC Capital Markets thinks you can make money?

The top buys in the sector, listed.

Read more »